Press release - 21/04/2021 A study identifies the top 50 life and biological sciences and technologies driving innovation in the bio-based sectors in Europe. The study “Life and Biological Sciences and Technologies as Engines for Bio-based Innovation”, funded by the European Commission, DG Research and Innovation has been published and is now available for download from the website of the Publications Office of the European Union.https://www.biooekonomie-bw.de/en/articles/pm/study-identifies-top-50-life-and-biological-sciences-and-technologies-driving-innovation-bio-based-sectors-europe
Press release - 14/04/2021 Engineering T cells for cancer therapy efficiently and safely Genetically enhancing a patient's immune cells by adding therapeutic genes to them outside the body is regarded as a promising new treatment approach in oncology. However, the production of these therapeutic cells using viruses is not only expensive but time-consuming. Researchers at the German Cancer Research Center (DKFZ) have developed an innovative non-viral vector that can efficiently introduce therapeutic genes into immune cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/engineering-t-cells-cancer-therapy-efficiently-and-safely
Press release - 13/04/2021 Evotec’s BRIDGE “beLAB2122” leverages academic innovation from our region Evotec SE announced today the launch of beLAB2122 in the Rhine- Main-Neckar region to efficiently advance first-in-class therapeutic concepts into investable drug discovery projects. Mediated and supported by BioRN, Evotec’s newest BRIDGE brings together the European Molecular Biology Laboratory (“EMBL”), the German Cancer Research Center (“DKFZ”), the Goethe University Frankfurt, Heidelberg University and the University of Tübingen.https://www.gesundheitsindustrie-bw.de/en/article/press-release/evotecs-bridge-belab2122-leverages-academic-innovation-our-region
Press release - 08/04/2021 How to enhance innovative value chains in the bioeconomy in the Alpine Space? The European Interreg project AlpLinkBioEco in comes April 2021 to a successful end. The final conference of the project was conducted on the 31st of March 2021 and attracted over 160 participants from different parts of Europe. AlpLinkBioEco, of which BIOPRO Baden-Württemberg is a partner, has been running for three years (2018-2021) as part of the EU-Strategy for the Alpine Region (EUSALP).https://www.bio-pro.de/en/information/press-release/how-enhance-innovative-value-chains-bioeconomy-alpine-space
Quantum Technology Ulm - 08/04/2021 Diamonds for life sciences innovations The world's first commercial quantum computer,’IBM Q System One’, is now in operation in Ehningen near Stuttgart. This is a major leap forward in quantum technology in Germany. It marks the point at which conventional computers reach their limits. The University of Ulm is involved in three of six collaborative projects being funded by the Baden-Württemberg Ministry of Economic Affairs, Labour and Housing Construction.https://www.gesundheitsindustrie-bw.de/en/article/news/diamonds-life-sciences-innovations
Microfluidics in medical technology - 24/03/2021 Ultra-compact: valves with shape memory actuators Karlsruhe-based company memetis shows that this is possible. Intelligent components for controlling fluids open up huge potential in the medical technology and biotechnology sectors - from vaccine development and cell line analysis to drug research and point-of-care solutions.https://www.gesundheitsindustrie-bw.de/en/article/news/ultra-compact-valves-shape-memory-actuators
Press release - 23/03/2021 AFYREN and Südzucker reach long term deal to supply factory producing biobased organic acids AFYREN secures procurement of sugar beet co-products, major feedstock for industrial- scale production of its sustainable chemicals.https://www.biooekonomie-bw.de/en/articles/pm/afyren-and-sudzucker-reach-long-term-deal-supply-factory-producing-biobased-organic-acids
Press release - 18/03/2021 DBFZ presents exensively expanded online database on biogenic raw materials Systematically prepared and easily accessible research data can provide an essential basis for decision-making for a wide range of stakeholders from politics, science and industry. The resource database developed by the DBFZ, which contains a wealth of information on various biomass potentials and their current use, has been extensively expanded and is now also available in two languages (DE/EN) with a variety of new functionalities.https://www.biooekonomie-bw.de/en/articles/pm/dbfz-presents-exensively-expanded-online-database-biogenic-raw-materials
Press release - 23/02/2021 Commission gives the green light to the successor of BBI JU The European Commission agreed on the successor of BBI JU – the Circular Bio-based Europe Joint Undertaking (CBE JU) in a legislative proposal adopted today. The new partnership between the EU and the Bio-based Industries Consortium (BIC) is expected to build on the success of BBI JU while stepping up its contribution to the EU’s climate targets, in line with the European Green Deal. The European Parliament and Council will now study the…https://www.biooekonomie-bw.de/en/articles/pm/commission-gives-green-light-successor-bbi-ju
Article - 17/02/2021 Whole blood model enables development of early warning system for sepsis Sepsis is a life-threatening disease that can be treated all the more successfully the faster therapy is initiated. It is not just the infection itself that is so dangerous, but a dysregulated response of the immune system. Physicians at Ulm University Hospital have now developed an animal-free test system that can be used to research the disease and develop innovative diagnostic tools to quickly assess a patient's sepsis risk and optimise…https://www.gesundheitsindustrie-bw.de/en/article/news/whole-blood-model-enables-development-early-warning-system-sepsis
Press release - 08/02/2021 Water-repellent and more: coating textiles sustainably with chitosan Textiles can be coated with the biopolymer chitosan and thus made water-repellent by binding hydrophobic molecules. The good thing is that this can also replace toxic and petroleum-based substances that are currently used for textile finishing. In the last few years Fraunhofer IGB and partners have developed technology to provide fibers with the desired properties using biotechnological processes and chitosan.https://www.biooekonomie-bw.de/en/articles/pm/Water-repellent-and-more-coating-textiles-sustainably-with-chitosan
AI application potential & Matchmaking - 22/04/2021 - 06/05/2021 Application Potential of Artificial Intelligence in the Pharmaceutical Industry Onlinehttps://www.gesundheitsindustrie-bw.de/en/event/ki-in-der-pharmaindustrie
AI application potential & Matchmaking - 22/04/2021 - 06/05/2021 Application Potential of Artificial Intelligence in the Pharmaceutical Industry Onlinehttps://www.bio-pro.de/en/events/past-events/ki-in-der-pharmaindustrie
Press release - 05/02/2021 Showcase Bioeconomy: Intelligent Robot Helps Preserve Orchard Meadows University of Hohenheim project contributes to maintaining valuable biotopes: Autonomous robot to help prune fruit trees so they stay healthy.https://www.biooekonomie-bw.de/en/articles/pm/Showcase-Bioeconomy-Intelligent-Robot-Helps-Preserve-Orchard-Meadows
Press release - 01/02/2021 Targeting a rapid market breakthrough for new vaccine production method In a so-called inactivated or killed vaccine, the virus particles it contains are first rendered inactive by means of the toxic chemical formaldehyde. A better way of achieving this, however, is to irradiate the pathogens with low-energy electrons. Four Fraunhofer Institutes have now developed a new method of vaccine production based on this technique that is not only quicker but also guarantees a higher quality of product. https://www.gesundheitsindustrie-bw.de/en/article/press-release/targeting-rapid-market-breakthrough-new-vaccine-production-method
Press release - 29/01/2021 The added value of compostable plastics for the circular economy For quite some time now, the European Commission (EC) is putting a special focus on biodegradable and compostable polymers when assessing the general role of bioplastics. https://www.biooekonomie-bw.de/en/articles/pm/added-value-compostable-plastics-circular-economy
Development of biogenic packaging - 16/11/2020 Sustainable packaging - the devil is in the detail Modern packaging often boils down to a tick list of biogenic origin and/or biodegradability. But comprehensive sustainable packaging concepts need more than just that. Perishable foods, for example, require special barrier properties. The Albstadt-Sigmaringen University of Applied Sciences is researching packaging concepts for their sustainability.https://www.biooekonomie-bw.de/en/articles/news/sustainable-packaging-devil-detail
Lab-on-a-chip - 11/11/2020 Microfluidic platform for the best possible cancer therapy Every tumour and every patient is different, and there are individual reactions to drugs as well as the problem of resistance. Patient-specific cancer treatments require innovative and cost-effective approaches. The TheraMe! consortium has developed a novel instrument: a combination of microfluidic experiments and mathematical modelling for use in cancer precision medicine to prevent incorrect therapy options.https://www.gesundheitsindustrie-bw.de/en/article/news/microfluidic-platform-best-possible-cancer-therapy
Dossier - 09/11/2020 Packaging of the future What will the packaging of the future look like, and what will be required of it? Can packaging be biobased, recyclable, sustainable and economic? In Baden-Württemberg, there are various approaches to developing packaging with the above properties from various sources including agricultural residual and side streams as well as municipal waste.https://www.biooekonomie-bw.de/en/articles/dossiers/packaging-future
Inside the fight against COVID-19 - 28/10/2020 A new immunotherapeutic agent for treating severe COVID-19 cases Apogenix, a Heidelberg-based biopharmaceutical company specialising in innovative immunotherapeutics, has initiated a Phase II clinical trial with asunercept, the company’s lead drug candidate for treating severe cases of COVID-19. The fusion protein blocks the CD95-ligand-mediated death of epithelial cells in the lung and thus prevents damage to the organ.https://www.gesundheitsindustrie-bw.de/en/article/news/new-immunotherapeutic-agent-treating-severe-covid-19-cases
Innovative Therapies - 20/08/2020 Labor Dr. Merk is fully committed to viral therapies Labor Dr. Merk & Kollegen is reorienting its business towards viral therapeutics. With this change of strategy, the company, which has decades of expertise in virology, wants to position itself in a timely fashion in the growing new market for advanced therapy medicinal products (ATMP). In gene and virotherapies (oncolytic viruses), tumour vaccines and CAR-T cell therapies, viruses are essential as vectors, killers of tumour cells or…https://www.gesundheitsindustrie-bw.de/en/article/news/labor-dr-merk-fully-committed-viral-therapies
Microstructure Technology - 17/07/2020 An electronic nose for many applications Sensory organs are sophisticated masterpieces of nature. That is why humans have often tried to copy them. Be it cameras or microphones - there are technical objects that have always been based on natural models such as the eye or the ear. For a long time, however, no artificial sense of smell has featured in the technical repertoire. Now researchers at the Karlsruhe Institute of Technology (KIT) have developed an electronic nose. It can…https://www.gesundheitsindustrie-bw.de/en/article/news/electronic-nose-many-applications
Review article (new edition) - 08/07/2020 Immunology – at the forefront of medical progress Immunology is constantly changing with the emergence of new technologies and areas of application, and has branched out in many directions. Immunological approaches are central to everything – be it the development of innovative active substances and vaccinations against cancer, the search for new therapies against neurodegenerative diseases or autoimmune diseases, or combatting well-known infectious diseases or new virus epidemics.https://www.gesundheitsindustrie-bw.de/en/article/dossier/immunology-forefront-medical-progress
SICOS BW GmbH - 18/06/2020 High-performance computing and data analytics to combat coronavirus In an epidemic, data exchange and the use of innovative technologies are essential to be able to act effectively and quickly against the infection. High-performance computers and data analytics make a valuable contribution to this. SICOS BW is a promising solution centre that bridges the gap from numerical simulation, big data and AI to companies in the medical technology sector.https://www.gesundheitsindustrie-bw.de/en/article/news/high-performance-computing-and-data-analytics-to-combat-coronavirus
Innovations in the field of endoscopy - 08/06/2020 Gastroscopies with pill cameras A pill camera to examine the gastrointestinal tract that can be swallowed without major difficulty, controlled intuitively from the outside and deliver images in real time - why would any doctor or patient say no? To non-experts, it sounds more like science fiction but such a device is actually already in development: since 2019, Tübingen-based Ovesco Endoscopy AG and three partners have been working together on this in a project called nuEndo.https://www.gesundheitsindustrie-bw.de/en/article/news/magenspiegelung-kamerapille